BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 1349793)

  • 1. Prediction of drug resistance in human tumors using immunohistochemical techniques.
    Mattern J; Volm M
    Anticancer Res; 1992; 12(2):413-8. PubMed ID: 1349793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of resistance proteins in matched primary lung tumors and lymph node metastases.
    Mattern J; Volm M
    Anticancer Res; 1994; 14(2A):417-9. PubMed ID: 7912493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of several resistance mechanisms in untreated human kidney and lung carcinomas.
    Volm M; Mattern J; Efferth T; Pommerenke EW
    Anticancer Res; 1992; 12(4):1063-7. PubMed ID: 1354430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of P-glycoprotein, glutathione-based detoxifying enzymes and O6-alkylguanine-DNA alkyltransferase as potential indicators of constitutive drug resistance in human colorectal tumors.
    Redmond SM; Joncourt F; Buser K; Ziemiecki A; Altermatt HJ; Fey M; Margison G; Cerny T
    Cancer Res; 1991 Apr; 51(8):2092-7. PubMed ID: 1672623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of genes of potential importance in the response to chemotherapy and DNA repair in patients with ovarian cancer.
    Codegoni AM; Broggini M; Pitelli MR; Pantarotto M; Torri V; Mangioni C; D'Incalci M
    Gynecol Oncol; 1997 Apr; 65(1):130-7. PubMed ID: 9103402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of drug resistance in human lung cancer cells.
    Doyle LA
    Semin Oncol; 1993 Aug; 20(4):326-37. PubMed ID: 8102011
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
    Jain N; Lam YM; Pym J; Campling BG
    Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multidrug resistance of neoplastic cells--facts and hypotheses].
    Grzelakowska-Sztabert B
    Postepy Biochem; 1989; 35(4):513-41. PubMed ID: 2577370
    [No Abstract]   [Full Text] [Related]  

  • 9. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoresistance to doxorubicin and cisplatin in a murine cell line. Analysis of P-glycoprotein, topoisomerase II activity, glutathione and related enzymes.
    Mestdagh N; Pommery N; Saucier JM; Hecquet B; Fournier C; Slomianny C; Teissier E; Hénichart JP
    Anticancer Res; 1994; 14(3A):869-74. PubMed ID: 7915509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Hepatogastroenterology; 2008; 55(86-87):1530-6. PubMed ID: 19102336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical detection of P glycoprotein, glutathione S transferase and DNA topoisomerase II in human tumors.
    Efferth T; Mattern J; Volm M
    Oncology; 1992; 49(5):368-75. PubMed ID: 1356260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple drug resistance parameter expression in ovarian cancer.
    Joncourt F; Buser K; Altermatt H; Bacchi M; Oberli A; Cerny T
    Gynecol Oncol; 1998 Aug; 70(2):176-82. PubMed ID: 9740686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular resistance against the novel hybrid anthracycline N-(2-chloroethyl)-N-nitrosoureidodaunorubicin (AD 312) is mediated by combined altered topoisomerase II and O6-methylguanine-DNA methyltransferase activities.
    Pawlik CA; Israel M; Sweatman TW; Lothstein L
    Oncol Res; 1998; 10(4):209-17. PubMed ID: 9778692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance.
    Schneider E; Horton JK; Yang CH; Nakagawa M; Cowan KH
    Cancer Res; 1994 Jan; 54(1):152-8. PubMed ID: 7903202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.
    Hamaguchi K; Godwin AK; Yakushiji M; O'Dwyer PJ; Ozols RF; Hamilton TC
    Cancer Res; 1993 Nov; 53(21):5225-32. PubMed ID: 8106143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of the drug resistance markers DNA topoisomerase II alpha and glutathione S-transferase-pi in the histological compartments of Wilms' tumors.
    Granzen B; Efferth T; Keller U; Beniers AJ; Mertens R; Jakse G; Füzesi L
    Anticancer Res; 2001; 21(1B):771-6. PubMed ID: 11299842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line.
    de Jong S; Zijlstra JG; de Vries EG; Mulder NH
    Cancer Res; 1990 Jan; 50(2):304-9. PubMed ID: 1967222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of protein kinase C, proto-oncogene products and resistance-related proteins in newly diagnosed childhood acute lymphoblastic leukemia.
    Volm M; Zintl F; Edler L; Sauerbrey A
    Med Pediatr Oncol; 1997 Feb; 28(2):117-26. PubMed ID: 8986147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of etoposide resistance in non-P-glycoprotein expressing multidrug resistant tumor cell lines by novobiocin.
    Rappa G; Lorico A; Sartorelli AC
    Cancer Res; 1993 Nov; 53(22):5487-93. PubMed ID: 8106148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.